Jacobs Engineering Group Inc. (NYSE:JEC) announced today it acquired the patent rights for BAYQIK ® quasi-isothermal sulfuric acid converter technology and other related technology from Bayer AG. Under the terms of the agreement, the technology transfer includes all relevant Bayer technical, commercial and market information. In addition, Bayer is providing transitional services to help ensure a seamless transfer of the BAYQIK business. Terms of the transaction will not be disclosed. BAYQIK technology enables more efficient conversion of process gas with high SO 2 concentrations. Bayer developed, piloted and commercialized the technology over the past 10 years. A full-scale installation based on the technology has operated successfully for seven years. Commenting on the announcement, Jacobs President Petroleum and Chemicals Gary Mandel said the acquisition complements Jacobs' existing sulfuric acid technology portfolio, enabling the company to provide state-of-the-art technology to both the low strength and high strength SO 2 market segments. "This acquisition is an exciting development for our Chemetics process technology solutions business and our process industry clients," said Mandel. "BAYQIK is proven to be a superior and more flexible option for processing high strength SO 2 gas, a growing requirement for clients in the non-ferrous metallurgical acid plant market. "We're thrilled to add this robust technology to our sulfuric acid technology portfolio and offer this capability to clients by leveraging the global reach of Jacobs' network." Jacobs is one of the world's largest and most diverse providers of full-spectrum technical, professional and construction services for industrial, commercial and government organizations globally. The company employs 50,000 people and operates in more than 30 countries around the world. For more information, visit www.jacobs.com. Statements made in this release that are not based on historical fact are forward-looking statements. We base these forward-looking statements on management's current estimates and expectations as well as currently available competitive, financial and economic data. Forward-looking statements, however, are inherently uncertain. There are a variety of factors that could cause business results to differ materially from our forward-looking statements. For a description of some of the factors which may occur that could cause actual results to differ from our forward-looking statements please refer to our 2015 Form 10-K, and in particular the discussions contained under Items 1 - Business, 1A - Risk Factors, 3 - Legal Proceedings, and 7 - Management's Discussion and Analysis of Financial Condition and Results of Operations. We do not undertake to update any forward-looking statements made herein.